What is it?
A booster to transform groundbreaking ideas in the field of target identification, disease knowledge and translational science into innovative therapeutic solutions. We partner with best-in-class academics to serve a common goal: accelerating innovation for patients.
Call for projects open from April 22nd until June 3rd 2024
Only principal investigators belonging to one of the iAwards partner institutions are eligible to this call. For more information, please contact EMEA_iAwards-Europe@sanofi.com.
About the program
- A seed funding of 120 000 euros.
- A dedicated support of a Sanofi scientific expert.
- A steppingstone to further collaboration.
Who are we looking for?
Principal investigators from academic partner institutions developing cutting-edge therapeutic solutions in the following areas:
- Oncology
- Immunology and inflammatory diseases
- Rare and Neurological diseases
- Cell and gene therapies
- Vaccines
- Precision Medicine in Immunology
iAwards 2023: ongoing projects
Mariano BARBACID
CNIO (Spain)
Jean-François PEYRON
INSERM (France)
Thierry WALZER
CIRI / INSERM (France)
Marc BITOUN
INSERM (France)
Hervé BOUTIN
INSERM (France)
Elisabeth TRAIFFORT
INSERM (France)
Stéphanie LONGET
CIRI /INSERM (France)
Jessica QUINTIN
Institut Pasteur (France)
iAward Program Partners
France
Assistance Publique – Hôpitaux de Paris
Centre Léon Bérard
Centre International de Recherche en Infectiologie
Gustave Roussy
INSERM
Institut Curie
Institut de la Vision
Institut Imagine
Institut Pasteur
Israel
Weizmann Institute
Spain
Spanish National Cancer Research Centre
Germany
Berlin Institute of Health at La Charité
German Cancer Research Center
Ludwig Maximilians Universität München
Max Delbrück Center
Translational Oncology
United Kingdom
Cambridge University
King’s College London
The Netherlands
The Netherlands Cancer Institute
Switzerland
Université de Genève
For more information
contact EMEA_iAwards-Europe@sanofi.com